ADMA Biologics ADMA
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$15.83M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 35.6% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 10.13% to 8.05% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +2,242,671 | 4.5% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +561,050 | 0.3% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q3 | +514,606 | 0.2% |
| Principal Global Investors, LLC | Mutual Fund | 2026/Q3 | +497,985 | 0.8% |
| Clark Estates Inc. | Family Office/Trust | 2026/Q3 | +278,000 | 0.1% |
| Bridge City Capital, LLC | Mutual Fund | 2026/Q3 | +265,689 | 0.1% |
| Frontier Capital Management | Mutual Fund | 2026/Q3 | +785,781 | 0.4% |
| Rubric Capital Management LP | Hedge Fund | 2026/Q3 | +7,530,006 | 4.2% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +7,438,134 | 3.5% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +4,713,770 | 2.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +3,031,817 | 7.6% |
| Nantahala Capital Management, LLC | Hedge Fund | 2026/Q3 | +2,359,993 | 1.1% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,524,910 | 17.1% |
| Life Cycle Investment Partners Limited | Mutual Fund | 2026/Q3 | +1,522,981 | 0.7% |
| Kennedy Capital Management LLC | Mutual Fund | 2026/Q3 | +1,343,805 | 0.8% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 4 Nov 2026 | Adam Grossman | Chief Executive Officer | Open Market Disposition | -42,000 | $12.00 | 2,901,326 |
| 4 Nov 2026 | Adam Grossman | Chief Executive Officer | Derivative Exercise and Sale | -105,000 | $12.00 | 2,901,326 |
| 23 Jul 2026 | Kaitlin Kestenberg | COO & Senior VP of Compliance | Sale to Issuer | -3,177 | $8.37 | 165,682 |
| 15 Jul 2026 | P. Terence Kohler | Chief Financial Officer | Other Acquisition | +85,130 | – | 143,149 |
| 15 Jul 2026 | P. Terence Kohler | Chief Financial Officer | Other Derivative Acquisition | +136,363 | $8.81 | 136,363 |
| 26 May 2026 | Jerrold Grossman | Co-Founder & Vice Chairman of the Board | Open Market Acquisition | +6,400 | $7.91 | 564,007 |
| 11 May 2026 | Jerrold Grossman | Co-Founder & Vice Chairman of the Board | Open Market Acquisition | +12,500 | $8.01 | 557,607 |
| 10 May 2026 | Jerrold Grossman | Co-Founder & Vice Chairman of the Board | Open Market Acquisition | +12,500 | $8.01 | 545,107 |
| 31 Mar 2026 | Kaitlin Kestenberg | COO & Senior VP of Compliance | Sale to Issuer | -20,362 | $9.11 | 161,359 |
| 16 Mar 2026 | Lawrence Guiheen | Independent Director | Other Acquisition | +30,000 | – | 175,820 |
| 16 Mar 2026 | Lawrence Guiheen | Independent Director | Derivative Exercise and Sale | -30,000 | – | 175,820 |
| 15 Mar 2026 | Adam Grossman | Chief Executive Officer | Automatic Disposition | -6,000 | $15.16 | 2,943,326 |
| 15 Mar 2026 | Adam Grossman | Chief Executive Officer | Derivative Exercise and Sale | -15,000 | $15.16 | 2,943,326 |
| 9 Mar 2026 | Brad Tade | Former Consultant | Intent to Sell (Form 144) | -50,026 | $15.81 | – |
| 8 Mar 2026 | Kaitlin Kestenberg | COO & Senior VP of Compliance | Other Disposition | -91,266 | – | 133,641 |
| 8 Mar 2026 | Kaitlin Kestenberg | COO & Senior VP of Compliance | Derivative Exercise and Sale | -10,096 | $15.63 | 133,641 |
| 6 Mar 2026 | Adam Grossman | Chief Executive Officer | Sale to Issuer | -85,951 | $15.39 | 2,949,326 |
| 6 Mar 2026 | Kaitlin Kestenberg | COO & Senior VP of Compliance | Sale to Issuer | -14,294 | $15.39 | 133,641 |
| 5 Mar 2026 | Aisling Capital Management LP | Open Market Acquisition | +14,000 | $15.67 | – | |
| 25 Feb 2026 | P. Terence Kohler | Chief Financial Officer | Initial Statement of Beneficial | +0 | – | 58,019 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 18,035,119 | 8.1% | 7.1 |
| 15 Oct 2026 | 19,528,063 | 8.7% | 6.6 |
| 30 Sep 2026 | 20,597,867 | 9.2% | 5.7 |
| 15 Sep 2026 | 24,206,749 | 10.8% | 10.8 |
| 31 Aug 2026 | 23,870,475 | 10.7% | 13.9 |
| 14 Aug 2026 | 22,683,647 | 10.1% | 8.0 |
No comments yet — be the first to weigh in on ADMA.
Sign in to join the discussion.